Drug Development and Approval: A Joint Pharma Presentation on Advocacy

Description: Discussions on the important and active role that trial participants play in research and drug development, and on recent developments in pharmaceutical research for Alzheimer’s disease
Runtime: 00:28:17

Speaker: Rachel J. Schindler, MD
Speaker title: Vice President, Clinical Disease Area Expert, Neurosciences
Speaker organization: Pfizer

Speaker: Johan Luthman, MD, PhD
Speaker title: Vice President, Neuroscience Clinical Development
Speaker organization: Eisai Neurology Business Group

Event: 2016 DIAD Family Conference: Too Young to Forget
Location: Toronto, Ontario, Canada
Year: 2016

Search tags: drug development, biomarkers, preclinical studies, drug targets, drugability, BASE enzyme, disease modification, research participation, preclinical Alzheimer’s, risk factors, amyloid, cognitive testing, diagnosis, public-private partnership, clinical trials, family support, advocacy, trial eligibility, informed consent, recruitment, patient voices, primary care